Form 4: Gregg Williams Buys VANI Stock
Statement of Changes in Beneficial Ownership
Gregg Williams, a Director and 10% Owner of Vivani Medical, Inc., has acquired 1,587,301 shares of common stock in a private sale.
Summary
- Gregg Williams, a Director and 10% Owner of Vivani Medical, Inc. (VANI), purchased 1,587,301 shares of common stock on May 15, 2026, for $1.26 per share.
- This transaction was part of a private sale agreement dated August 11, 2025, with gross proceeds of $1,999,999.26.
- Following this purchase, Williams beneficially owns a total of 34,531,785 shares of VANI common stock, held directly and indirectly through various trusts and entities.
Sentiment
Score: 7
Explanation: StockSavvy.ai views this as a positive development due to a significant insider purchase, indicating strong confidence from a key stakeholder.
Positives
- Significant share acquisition by a key insider (Director and 10% Owner) indicates confidence in the company's future.
- The purchase price of $1.26 per share was based on the last reported sale price on the Nasdaq prior to the agreement date, suggesting a fair market valuation at the time of the agreement.
- The reporting person has committed to providing further information upon request, demonstrating transparency.
Negatives
- The filing does not provide details on the specific reasons for the sale by the previous owner or the company's need for capital, if any.
- A large number of shares (4,799,200) were disposed of in a separate transaction, though the details and counterparty are not specified.
Risks
- The filing does not explicitly mention any new risks associated with this transaction.
- Potential future dilution could occur if the capital raised from this private sale is used for expansion or if further share issuances are planned.
Future Outlook
The filing itself does not contain forward-looking statements or guidance. However, the insider purchase suggests a positive outlook from the reporting person.
Industry Context
StockSavvy.ai notes that insider purchases, particularly by directors and significant shareholders, are often interpreted as a strong signal of confidence in the company's prospects and can influence investor sentiment within the biotechnology and medical technology sectors.
Related Party Transactions
- Gregg Williams, a Director and 10% Owner, purchased 1,587,301 shares of common stock in a private sale transaction.
Stakeholder Impact
- Shareholders: The purchase by a key insider may signal confidence, potentially positively impacting share price. It also clarifies beneficial ownership structures.
- Company: The transaction represents a capital infusion of nearly $2 million, which can be used for operational needs or strategic initiatives.
Next Steps
- The reporting person undertakes to provide full information regarding the number of shares purchased upon request from the Issuer, any security holder, or the SEC staff.
Key Dates
| Date | Description |
|---|---|
| 08/11/2025 | Date of Share Purchase Agreement. |
| 05/15/2026 | Transaction Date for the purchase of common stock. |
| 05/19/2026 | Date of signature for the Form 4 filing. |
Recommendation
holdThe insider purchase is a positive signal, but without broader financial performance data or strategic updates in this specific filing, a 'hold' recommendation is prudent. Further analysis of the company's overall financial health and strategic direction is warranted.
Keywords
Vivani Medical, VANI, Form 4, Insider Transaction, Share Purchase, Beneficial Ownership, Gregg Williams, SEC Filing, Common Stock
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.